Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01867372 · ClinicalTrials.gov registry record

Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes

A clinical trial, sponsored by National Institute on Aging (NIA).

Terminated
Registry status
213
Enrollment target

NCT01867372: Clinical Trial study, sponsored by National Institute on Aging (NIA).

NCT01867372 is a clinical trial that was terminated before completion, run by National Institute on Aging (NIA). The registered enrollment target is 213 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01867372 was terminated before completion, sponsored by National Institute on Aging (NIA).

TERMINATED
Registry status
213 participants
Enrollment target

Study Summary

Background: \- Participants in the Baltimore Longitudinal Study of Aging are being studied to examine changes in brain structure and function over time, and to determine if these changes can predict the likelihood that an individual will develop thinking and memory impairments such as Alzheimer s disease later in life. Imaging studies and neuropsychological testing have been conducted on current participants, and new participants are being recruited to the study. To develop better treatments and therapies for aging-related memory loss and other disorders, researchers are interested in determining whether early prediction of thinking and memory impairments are accurate and in evaluating factors that affect these predictions. Objectives: \- To use imaging studies and tests of thinking and memory to determine early markers of Alzheimer s disease and other cognitive impairments. Eligibility: \- Current participants and new recruits to the Baltimore Longitudinal Study of Aging. Design: * Participants will be screened with a full medical history and physical examination, as well as blood and urine tests. * Participants will have testing visits as directed by the study researchers. All participants will have tests as part of their an initial enrollment in the study, and may be asked to return yearly, 2 years later, or 4 years later for repeated tests. * At each visit, participants will have brain imaging scans (including magnetic resonance imaging and/or magnetic resonance spectroscopy to measure brain structure and function, and positron emission tomography to study blood flow in the brain) to evaluate brain structure and function. Participants will also take tests of memory and problem-solving skills. * Treatment will not be provided as part of this protocol.

Trial Details

FieldValue
Enrollment Target 213 participants
Start Date 2003-03-10
Est. Completion 2014-09-22
National Institute on Aging (NIA)

131 total trials

Why NCT01867372 stopped before completion

NCT01867372 is an observational study that tracks outcomes without assigning an intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01867372 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01867372 about?

NCT01867372 is a clinical study titled "Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes". Background: \- Participants in the Baltimore Longitudinal Study of Aging are being studied to examine changes in brain structure and function over time, and to determine if these changes can predict the likelihood that an individual will develop thinking and memory impairments such as Alzheimer s d...

What is the current status of trial NCT01867372?

This trial is currently terminated. The enrollment target is 213 participants. The study started on 2003-03-10. Estimated completion is 2014-09-22.

Who is sponsoring clinical trial NCT01867372?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06476886 · 213 participants · NA

    Intensive Crisis Intervention

  • NCT06544655 · 213 participants · Phase 1

    A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

  • NCT07186816 · 213 participants · NA

    SUpport From PEeRs to Expand Access Study - Community

  • NCT04030507 · 214 participants · NA

    Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01867372, the US trial registry maintained by the National Library of Medicine. NCT01867372 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.